Familial Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Familial Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-02-24FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for pravastatin sodium from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS other · 2025-02-19Clinical Trial Update: High Intensity Interval Training in the Treatment of Familial Hypercholesterolemia (UPPA-FH) [NA]
This clinical trial update describes a study evaluating high-intensity interval training as a treatment for familial hypercholesterolemia, w…
-
FDA label_change · 2025-02-12FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for EZALLOR SPRINKLE (rosuvastatin) to support the sprinkle dosage-form labeling. This action expand…
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for rosuvastatin calcium submitted by Sun Pharmaceutical Industries, Inc., approving an additional f…
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for rosuvastatin submitted by ScieGen Pharmaceuticals, enabling the marketing of a generic rosuv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-14FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Rosuvastatin Calcium from Ascend Laboratories, LLC, supporting the continued availability of a r…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Genetic Testing and Motivational Counseling for FH [NA]
This clinical trial update describes an ongoing study evaluating genetic testing and motivational counseling to support adherence in people …
-
FDA approval · 2024-12-17FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for atorvastatin calcium (generic) from Ascend Laboratories, LLC, for this ANDA, approving regulator…
-
FDA approval · 2024-12-04FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
FDA approved a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc., enabling the generic atorvastatin …
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Clinical Decision Support for Familial Hypercholesterolemia [NA]
This is an update on a clinical trial evaluating clinical decision support for familial hypercholesterolemia. The study is currently recruit…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan
A long-term post-marketing specified drug use survey for evolocumab conducted in Japan has completed.
-
FDA approval · 2024-11-20FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
The FDA approved a supplemental application for Repatha (evolocumab) submitted by Amgen USA Inc.
-
FDA approval · 2024-11-06FDA Approved: ROSUVASTATIN — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for rosuvastatin by Macleods Pharmaceuticals Limited, establishing a generic rosuvastatin product. Thi…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction [Phase 3]
Phase 3 open-label extension evaluating long-term efficacy and safety of LIB003 in patients with homozygous and heterozygous familial hyperc…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Unravelling the Impact of Diet on Cardiovascular Health in Treated Heterozygous Familial Hypercholesterolemia. [NA]
The clinical trial investigating how diet affects cardiovascular health in individuals with treated heterozygous familial hypercholesterolem…
-
FDA approval · 2024-10-16FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for rosuvastatin calcium from Rising Pharma Holdings, Inc., granting approval for a generic rosu…
-
FDA approval · 2024-10-15FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Glenmark Pharmaceutials Inc., USA)
FDA approved a supplemental application for rosuvastatin calcium from Glenmark Pharmaceuticals, confirming regulatory approval of this gener…
-
FDA approval · 2024-10-11FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Colesevelam hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2024-09-23FDA Approved: EZETIMIBE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for ezetimibe submitted by Sandoz Inc, updating the approved ezetimibe product.
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: PMMHRI - Familial Hypercholesterolemia Registry
Clinical trial registry entry for a Familial Hypercholesterolemia Registry sponsored by the Polish Mother Memorial Hospital Research Institu…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: The Use of Mobile Health Technology and Behavioral Economics to Encourage Adherence in Adolescents [NA]
A completed clinical trial evaluating a mobile health platform using behavioral economics to improve medication adherence in adolescents wit…
-
FDA approval · 2024-08-20FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
FDA approves a supplemental application for Repatha (evolocumab) from Amgen USA Inc., authorizing changes related to its labeling/indication…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) [Phase 3]
A Phase 3 trial comparing ezetimibe plus simvastatin versus simvastatin alone for progression of carotid artery atherosclerosis has complete…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED) [Phase 3]
A Phase 3 clinical trial of an Organon investigational drug for familial hypercholesterolemia and sitosterolemia was terminated.
-
FDA approval · 2024-07-26FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for atorvastatin calcium from Micro Labs Limited, updating the approval status of this generic stati…